This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of levodopa decarbox-comt-inhibitor
PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1154 |
4. Check minimum number of events
Min. number of events
3
|
1154 |
5. Include endpointsNone |
1154 |
6. Filter based on genotype QC (FinnGen only) |
1134 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Use of levodopa decarbox-comt-inhibitor
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1134 | 415 | 719 |
| Unadjusted period prevalence (%) | 0.26 | 0.15 | 0.33 |
| Median age at first event (years) | 69.93 | 68.97 | 70.48 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1154
- Matched controls
- 11540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N06DA03
ATC
rivastigmine; oral, transdermal
13.6
319.9
348
355
N04BC09
ATC
rotigotine; transdermal
248.3
307.7
221
11
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
167.7
307.7
280
22
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
307.7
1154
12
N87
ICPC
Parkinsonism
187.6
307.7
599
66
N04BC04
ATC
ropinirole; oral
256.0
307.7
471
31
N04BD02
ATC
rasagiline; oral
690.0
307.7
546
15
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
3962.9
307.7
1133
155
193
Kela drug reimbursment
Rasagiline
677.3
307.7
453
11
N04BD01
ATC
selegiline; oral
371.8
307.7
729
53
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2313.0
307.7
1129
221
N04BC05
ATC
pramipexole; oral
34.2
307.7
717
528
N04BB01
ATC
amantadine; oral
47.4
307.7
223
58
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
197.8
307.7
169
10
G20
ICD-10 Finland
Parkinson disease
4146.7
307.7
1136
173
N04BX02
ATC
entacapone; oral
729.8
295.1
279
5
N05AH04
ATC
quetiapine; oral
7.3
235.0
480
1022
N03AE01
ATC
clonazepam; systemic
10.6
220.9
274
328
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
60.8
169.8
95
17
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
26.3
159.1
112
47
N04AA02
ATC
biperiden; systemic
20.5
147.3
115
62
R25.1
ICD-10 Finland
Tremor, unspecified
11.0
141.9
161
167
XA800
NOMESCO Finland
Neuropsychological investigation
10.4
134.1
159
175
G04BD12
ATC
mirabegron; oral
4.8
125.4
370
1029
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
203.6
124.2
127
7
R1250
NOMESCO Finland
Evaluation of functional capability
11.9
111.1
117
108
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
26.5
110.6
77
31
H02AA02
ATC
fludrocortisone; oral
19.8
105.6
83
45
N04BC06
ATC
cabergoline; oral
49.5
104.7
61
13
N19
ICPC
Speech disorder
13.6
83.6
80
63
SPAT1229
SPAT
Assessment of need for aid
4.4
79.8
232
620
R4130
NOMESCO Finland
Speech therapy
8.8
78.8
103
127
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
12.4
78.1
79
68
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.9
74.6
182
422
Z2445
NOMESCO Finland
Psychologist
8.3
70.2
96
125
AA1AD
NOMESCO Finland
CT of head and brain
3.0
70.1
543
2669
N04BX04
ATC
opicapone; oral
351.9
67.3
67
*
A06AD11
ATC
lactulose; oral
3.2
67.2
355
1402
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
23.9
63.8
46
20
L28
ICPC
Limited function/disability (L)
3.0
62.2
383
1641
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
59.0
332
1347
R53
ICD-10 Finland
Malaise and fatigue
2.8
58.2
406
1850
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
203.3
56.5
58
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
56.3
538
2864
G02CB01
ATC
bromocriptine; systemic
17.1
55.0
46
28
I95.1
ICD-10 Finland
Orthostatic hypotension
4.7
54.3
134
311
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
4.7
52.5
129
298
N29
ICPC
Neurological sympt/complt other
8.0
51.9
72
95
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.8
51.4
179
536
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.4
51.4
108
218
A28
ICPC
Limited function/disability NOS
2.7
50.5
370
1709
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.7
50.5
124
286
SPAT1231
SPAT
Assessment of adjustments needed in living environment
6.7
48.8
80
127
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.5
48.7
83
137
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.9
47.5
283
1170
D21
ICPC
Swallowing problem
8.3
46.4
62
78
N06AX11
ATC
mirtazapine; oral
2.4
45.6
483
2633
XF606
NOMESCO Finland
Ortostatic test
13.0
45.4
44
35
C07AA05
ATC
propranolol; systemic
2.8
44.3
282
1202
N04BC02
ATC
pergolide; oral
122.4
44.1
47
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
44.0
372
1823
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.8
43.8
144
413
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
43.4
285
1233
SPAT1216
SPAT
Assessment of functional ability
2.6
41.6
316
1467
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
41.5
150
458
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.3
38.2
51
64
S01.0
ICD-10 Finland
Open wound of scalp
3.1
37.2
174
622
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
36.2
248
1087
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.3
36.1
151
505
U04
ICPC
Incontinence urine
3.6
36.0
130
396
N05BA04
ATC
oxazepam; oral
2.3
35.7
373
1979
Z50.5
ICD-10 Finland
Speech therapy
10.3
35.5
40
40
SPAT1234
SPAT
Support of social functional capacity
3.6
35.2
127
386
N30.0
ICD-10 Finland
Acute cystitis
2.7
35.1
231
991
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
35.0
449
2587
N06AB10
ATC
escitalopram; oral
2.6
34.7
233
1010
R1260
NOMESCO Finland
Evaluation of communicative skills
5.8
33.4
62
111
R35
ICD-10 Finland
Polyuria
3.1
33.2
153
541
R47.1
ICD-10 Finland
Dysarthria and anarthria
7.4
32.8
48
67
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.8
31.4
172
669
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
72.0
31.0
35
5
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
9.3
30.5
37
41
N04BC07
ATC
apomorphine; parenteral
+∞
30.3
29
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.3
29.5
61
121
N28
ICPC
Limited function/disability (N)
5.6
28.3
55
103
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
7.9
26.9
37
48
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.8
26.9
152
599
G04BD09
ATC
trospium; oral
4.7
26.9
63
139
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
26.6
266
1363
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
26.1
257
1308
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
7.6
26.0
37
50
N03AX12
ATC
[U] gabapentin; oral
2.3
25.8
246
1236
AA5EN
NOMESCO Finland
Brain reseptor or transprot protein distribution isotope imaging
33.9
25.7
33
10
S72.0
ICD-10 Finland
Fracture of neck of femur
3.2
24.8
102
336
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.3
24.1
64
156
F02.30
ICD-10 Finland
Dementia in Parkinson's disease without additional symptoms
244.9
23.7
24
*
G04BD08
ATC
solifenacin; oral
2.8
23.7
131
509
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.0
23.4
67
173
R5110, ,
SPAT
2.8
23.3
126
484
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
23.0
22
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
22.8
132
525
Z3226
NOMESCO Finland
Physiotherapist
2.1
22.7
266
1441
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.2
22.5
94
312
R13
ICD-10 Finland
Dysphagia
2.7
22.3
129
513
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
6.0
21.9
39
67
N05AH02
ATC
clozapine; systemic
8.2
21.8
29
36
J01EA01
ATC
trimethoprim; systemic
2.0
21.8
322
1895
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
21.7
129
520
M48.0
ICD-10 Finland
Spinal stenosis
2.2
21.6
221
1135
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
7.7
21.3
30
40
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.6
21.1
73
215
RF120, ,
NOMESCO Finland
6.8
20.9
33
50
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.9
20.5
105
391
AA1AA
NOMESCO Finland
Head X-ray examination
6.5
18.9
31
49
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
18.9
116
475
F0230, G20,
ICD-10 Finland
+∞
18.8
18
*
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
21.2
18.7
27
13
F02.32
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly hallucinations
101.7
18.6
20
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.9
18.6
93
342
W19
ICD-10 Finland
Unspecified fall
2.3
18.5
153
717
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.0
18.2
84
295
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
18.0
149
698
R32
ICD-10 Finland
Unspecified urinary incontinence
3.9
18.0
54
144
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
18.0
124
536
G04BD11
ATC
fesoterodine; oral
3.6
17.9
61
178
K59.0
ICD-10 Finland
Constipation
2.7
17.8
98
379
M41.9
ICD-10 Finland
Scoliosis, unspecified
6.3
17.7
30
49
N04BC01
ATC
bromocriptine; oral
96.6
17.6
19
*
N30.9
ICD-10 Finland
Cystitis, unspecified
2.8
17.5
93
353
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
42.7
17.3
21
5
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.4
17.2
64
198
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.0
17.0
49
127
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.3
16.9
64
200
K08.3
ICD-10 Finland
Retained dental root
2.4
16.6
118
517
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
18.2
16.5
25
14
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.6
16.4
55
159
J01CA08
ATC
pivmecillinam; oral
1.7
16.1
367
2434
RF420, ,
NOMESCO Finland
5.3
15.9
32
62
UKC02
NOMESCO Finland
Cystoscopy
1.8
15.8
272
1659
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
6.0
15.8
28
48
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.0
15.7
34
70
AA5QN, ,
NOMESCO Finland
162.1
15.5
16
*
Z75.5
ICD-10 Finland
Holiday relief care
5.8
15.4
28
49
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
15.0
15.4
25
17
SPAT1254
SPAT
Administration of medicine
1.9
15.3
212
1205
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
16.3
15.3
24
15
R23
ICPC
Voice symptom/complaint
4.4
14.6
37
87
R33
ICD-10 Finland
Retention of urine
2.1
14.5
157
816
N03AX16
ATC
[U] pregabalin
1.8
14.4
289
1839
N99
ICPC
Neurological disease other
4.9
14.3
31
64
K02.1
ICD-10 Finland
Caries of dentine
1.6
14.0
570
4350
F02.34
ICD-10 Finland
Dementia in Parkinson's disease, other additional symptoms of mixed type
141.6
13.5
14
*
XKD00
NOMESCO Finland
Uroflowmetry
1.7
13.5
280
1796
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
6.4
13.3
22
35
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
13.3
186
3032
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.3
13.1
49
152
N86
ICPC
Multiple sclerosis
16.9
13.0
20
12
RF410, ,
NOMESCO Finland
5.3
13.0
26
50
XKC03
NOMESCO Finland
Water cystometry
3.2
12.9
52
169
K03.66
ICD-10 Finland
Tooth plaque
2.4
12.9
94
416
R41.0
ICD-10 Finland
Disorientation, unspecified
2.9
12.9
63
229
F05.9
ICD-10 Finland
Delirium, unspecified
3.5
12.7
44
130
R60.0
ICD-10 Finland
Localized oedema
1.9
12.7
173
975
SPAT1167
SPAT
Insertion of urinary catheter
2.7
12.6
68
260
F0232, G20,
ICD-10 Finland
70.7
12.6
14
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
12.6
103
479
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.6
12.5
41
117
SPAT1244
SPAT
Occupational therapy
5.7
12.5
23
41
M54.5
ICD-10 Finland
Low back pain
1.6
12.4
371
2608
S70.0
ICD-10 Finland
Contusion of hip
2.7
12.4
66
251
A04
ICPC
Weakness/tiredness general
1.9
12.4
188
1096
N02BE01
ATC
paracetamol; systemic, rectal
2.0
12.3
1019
9156
G35
ICD-10 Finland
Multiple sclerosis
6.1
12.2
21
35
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.2
12.1
32
78
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
12.1
235
1475
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
11.9
122
621
G90.3
ICD-10 Finland
Multi-system degeneration
30.4
11.7
15
5
SPAT1172
SPAT
Guidance concerning hydration
3.4
11.6
42
128
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
11.5
367
2611
N06AX21
ATC
duloxetine; oral
2.0
11.3
125
654
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
35.4
11.3
14
*
H02AB06
ATC
prednisolone; systemic
0.6
11.3
313
4318
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
11.2
59
223
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
11.2
60
229
G25.2
ICD-10 Finland
Other specified forms of tremor
8.1
11.1
24
30
S06.0
ICD-10 Finland
Concussion
2.0
11.0
132
710
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
10.8
187
1132
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
10.7
10.8
20
19
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.0
10.8
46
155
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
10.7
212
1332
SFA10
NOMESCO Finland
One-surface restoration
1.5
10.6
531
4156
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
10.6
135
742
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
9.3
10.5
21
23
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.3
10.5
40
126
WX402
NOMESCO Finland
General anaesthesia
1.7
10.5
223
1430
N04BX01
ATC
tolcapone; oral
111.0
10.4
11
*
SCA02
NOMESCO Finland
Preventive oral health care
2.2
10.4
91
435
G21.8
ICD-10 Finland
Other secondary parkinsonism
32.8
10.3
13
*
L75
ICPC
Fracture: femur
4.1
10.3
28
70
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.2
10.3
41
133
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
23.6
10.3
14
6
S22.3
ICD-10 Finland
Fracture of rib
2.1
10.2
106
541
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.3
10.2
37
1020
Z3231
NOMESCO Finland
Registered nurse
1.6
10.2
322
2275
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.4
10.2
36
108
SPAT1262
SPAT
Handing over of treatment supplies
1.7
10.1
238
1567
L84
ICD-10 Finland
Corns and callosities
2.7
10.0
53
201
S01.8
ICD-10 Finland
Open wound of other parts of head
3.9
10.0
29
76
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.6
10.0
32
90
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.8
10.0
157
923
I95.9
ICD-10 Finland
Hypotension, unspecified
3.3
9.9
36
110
U07
ICPC
Urine symptom/complaint other
2.1
9.7
98
495
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
55.5
9.7
11
*
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
9.6
33
97
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
9.6
719
6058
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.6
9.6
57
230
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
7.2
9.5
22
31
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.9
9.5
45
161
130
Kela drug reimbursment
Malignant tumour
0.3
9.5
25
812
N87
ICD-10 Finland
Dysplasia of cervix uteri
+∞
9.4
9
*
F0234, G20,
ICD-10 Finland
+∞
9.4
9
*
EBA00
NOMESCO Finland
Extraction of tooth
1.5
9.4
367
2712
N30
ICD-10 Finland
Cystitis
2.2
9.3
76
353
N06AB04
ATC
citalopram; systemic
1.6
9.3
224
1478
R4110
NOMESCO Finland
Physiotherapy
1.5
9.2
320
2301
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.9
9.2
118
649
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
9.2
176
1095
SPAT1304
SPAT
Counselling and guidance related to ageing
1.9
9.1
117
644
L03AA13
ATC
pegfilgrastim; parenteral
0.0
9.1
*
255
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
9.0
125
705
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
15.7
9.0
14
9
N40
ICD-10 Finland
Hyperplasia of prostate
1.5
9.0
380
2845
A03FA01
ATC
metoclopramide; systemic, rectal
0.5
8.9
94
1699
R1250, ,
SPAT
3.7
8.9
28
78
I10
ICD-10 Finland
Essential (primary) hypertension
0.7
8.9
579
6859
H50.52
ICD-10 Finland
Exophoria
4.9
8.9
19
39
WYA20
NOMESCO Finland
Home visit
3.2
8.8
34
108
M03BX01
ATC
baclofen; systemic
3.4
8.8
31
93
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.7
8.8
46
174
N04AA01
ATC
trihexyphenidyl; oral
50.4
8.7
10
*
S01
ICD-10 Finland
Open wound of head
4.0
8.6
24
61
N02AA05
ATC
oxycodone; systemic
1.6
8.5
254
1762
R1420, ,
SPAT
27.7
8.5
11
*
H02AB02
ATC
dexamethasone; systemic
0.3
8.5
31
851
RF214, ,
NOMESCO Finland
90.7
8.4
9
*
IBC97
NOMESCO Finland
Other psychiatric aptitude assessment
90.7
8.4
9
*
RF210, ,
NOMESCO Finland
2.8
8.4
40
144
SPAT1125
SPAT
Stoma care and guidance
3.4
8.4
30
91
AA052, ,
NOMESCO Finland
+∞
8.3
8
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
8.3
49
197
SPAT1050
SPAT
Extensive neurological examination
3.1
8.3
33
107
S63.1
ICD-10 Finland
Dislocation of finger
3.7
8.2
25
68
R4190
NOMESCO Finland
Nutritional therapy
2.7
8.1
43
164
N08
ICPC
Abnormal involuntary movements
11.8
8.1
14
12
R44.1
ICD-10 Finland
Visual hallucinations
6.9
8.1
19
28
R63.4
ICD-10 Finland
Abnormal weight loss
2.3
8.1
58
256
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
3.1
8.1
33
109
H50.31
ICD-10 Finland
Intermittent exotropia
9.0
8.0
16
18
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
8.0
144
878
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.6
8.0
179
1159
G24.9
ICD-10 Finland
Dystonia, unspecified
13.1
7.9
13
10
E86
ICD-10 Finland
Volume depletion
2.6
7.8
43
167
W06
ICD-10 Finland
Fall involving bed
4.1
7.8
21
52
N06AX16
ATC
venlafaxine; oral
1.8
7.7
120
702
S01.9
ICD-10 Finland
Open wound of head, part unspecified
3.3
7.7
28
86
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.0
7.7
77
389
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.2
7.7
5
320
SPAT1301
SPAT
No procedures
1.5
7.7
364
2774
M79.6
ICD-10 Finland
Pain in limb
1.4
7.7
426
3344
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.6
596
4967
WX002
NOMESCO Finland
Sedation and analgesia
1.5
7.6
239
1673
K11.72
ICD-10 Finland
Xerostomia
25.2
7.6
10
*
C10AA07
ATC
rosuvastatin; oral
0.6
7.6
190
2739
R4120
NOMESCO Finland
Occupational therapy
2.1
7.5
75
378
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
7.5
141
870
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.5
475
3811
M04AA01
ATC
allopurinol; systemic
0.5
7.4
75
1381
Y94.0
ICD-10 Finland
Accident at home
3.2
7.4
28
88
H53.2
ICD-10 Finland
Diplopia
2.5
7.4
46
190
TKC22
NOMESCO Finland
Catheterisation instruction
2.6
7.4
42
166
S00.0
ICD-10 Finland
Superficial injury of scalp
2.8
7.4
37
137
N02BF01
ATC
gabapentin; oral
1.9
7.3
90
489
F023, G20,
ICD-10 Finland
+∞
7.3
7
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
7.3
7
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.4
7.3
25
74
R5599
NOMESCO Finland
Other rehabilitation service
2.6
7.2
40
156
M41.5
ICD-10 Finland
Other secondary scoliosis
15.9
7.2
11
7
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
3.1
7.2
29
95
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
7.2
210
1447
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
30.2
7.2
9
*
3010
Kela drug reimbursment
Midodrine
30.2
7.2
9
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
7.1
115
680
OAB43, ,
SPAT
0.2
7.1
13
519
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
7.1
298
2213
G23.1
ICD-10 Finland
Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]
12.1
7.1
12
10
R1100, ,
SPAT
10.1
7.0
13
13
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
7.0
7.0
16
23
R2110
NOMESCO Finland
Giving the first information
2.2
7.0
59
279
G04CB01
ATC
finasteride; oral
1.6
6.9
192
1306
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
6.9
259
1880
WX212
NOMESCO Finland
Femoral plexus blockade
2.6
6.8
37
143
SPAT1127
SPAT
Enema
4.1
6.8
18
44
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
11.0
6.8
12
11
J01DB01
ATC
cefalexin; oral
1.5
6.8
873
7860
L03
ICPC
Low back symptom/complaint
1.5
6.7
265
1940
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.4
6.7
23
68
N05BA06
ATC
lorazepam; systemic, sublingual
2.0
6.7
68
346
A01
ICPC
Pain general/multiple sites
1.8
6.7
105
617
R55
ICD-10 Finland
Syncope and collapse
1.6
6.6
147
948
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
6.6
180
1220
K02
ICD-10 Finland
Dental caries
2.0
6.6
69
355
Z29
ICPC
Social problem NOS
3.0
6.5
27
90
SFA20
NOMESCO Finland
Two-surface restoration
1.4
6.5
523
4340
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
6.5
70
364
C10AX09
ATC
ezetimibe; oral
0.5
6.5
77
1349
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.5
406
3234
S20.2
ICD-10 Finland
Contusion of thorax
2.1
6.4
62
309
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.9
6.4
78
422
K05.0
ICD-10 Finland
Acute gingivitis
3.3
6.4
23
70
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
6.4
94
540
AAG99
NOMESCO Finland
Other stereotactic intracranial operation
70.2
6.4
7
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
6.4
403
3208
R60.9
ICD-10 Finland
Oedema, unspecified
2.0
6.4
68
352
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.1
6.4
58
283
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
2.4
6.3
40
167
G04CA02
ATC
tamsulosin; oral
1.4
6.3
385
3049
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.4
6.3
41
174
G23.8
ICD-10 Finland
Other specified degenerative diseases of basal ganglia
18.1
6.3
9
5
F02.3
ICD-10 Finland
Dementia in Parkinson disease
+∞
6.3
6
*
F02.31
ICD-10 Finland
Dementia in Parkinson's disease other additional symptoms, mainly paranoidism
+∞
6.3
6
*
C01CA17
ATC
midodrine; oral
26.8
6.2
8
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
6.2
147
963
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.1
6.2
55
266
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
0.2
6.2
10
428
Z43.5
ICD-10 Finland
Attention to cystostomy
4.1
6.1
16
39
G24.8
ICD-10 Finland
Other dystonia
12.6
6.1
10
8
SFE01
NOMESCO Finland
Carriage renovation
12.6
6.1
10
8
F06.0
ICD-10 Finland
Organic hallucinosis
8.6
6.1
12
14
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.9
6.1
75
409
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
5.2
6.0
17
33
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.1
6.0
15
25
K04.1
ICD-10 Finland
Necrosis of pulp
1.7
6.0
98
582
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
58
28
21.76
77.30
2.1
1.2
105.87
160.53
nmol/l
0.61
31
19
834
6523
2.00
24.15
7.1
4.8
6613.36
1734.26
e6/l
0.64
22
119
357
2257
1.84
18.95
1.9
1.8
1242.33
1181.03
nmol/l
0.57
280
1681
519
3670
1.75
18.81
4.3
4.0
130.33
132.33
e6/l
0.02
390
2754
538
3888
1.72
17.69
3.7
3.4
—
—
—
0
0
470
3273
1.74
17.67
3.9
3.5
30.39
92.64
e6/l
2.38
367
2604
615
4640
1.70
17.00
5.3
4.0
0.00
0.00
estimate
0.50
141
938
723
8580
0.58
16.83
3.5
4.3
1.11
1.28
mmol/l
13.33
641
7617
757
8864
0.58
16.51
3.9
4.8
1.38
1.42
mmol/l
1.96
677
7942
432
2984
1.72
16.43
3.8
3.4
0.38
0.52
e6/l
1.00
340
2343
456
3199
1.70
16.36
2.7
2.2
240.82
237.50
u/l
0.02
439
2981
769
8940
0.58
15.75
3.8
4.9
4.27
4.43
mmol/l
4.32
691
8083
603
4615
1.64
15.05
7.2
5.4
0.00
0.00
estimate
-0.00
122
873
610
4683
1.64
15.03
5.3
4.0
0.00
0.00
estimate
0.50
123
846
389
2697
1.67
14.11
1.8
1.6
18.66
20.25
nmol/l
1.41
348
2267
581
4464
1.61
13.83
2.3
2.1
82.51
92.74
pmol/l
8.64
398
2349
744
6075
1.63
13.71
4.6
5.0
6.51
6.88
mmol/l
5.84
724
5747
476
3523
1.60
13.00
5.9
4.3
—
—
—
0
0
811
9174
0.61
12.38
4.3
5.5
2.47
2.56
mmol/l
2.32
725
8244
334
2303
1.63
12.02
2.9
2.7
5.17
4.32
e6/l
0.68
300
2092
649
5276
1.53
10.98
4.9
7.2
1.21
1.21
mmol/l
0.04
549
4463
224
3329
0.59
10.90
2.6
3.3
314.88
286.07
mg/l
0.04
151
2195
357
2563
1.57
10.62
5.4
4.3
0.00
0.00
estimate
0.50
114
818
228
3349
0.60
10.49
2.6
3.2
7.46
7.45
mmol/l
0.01
188
2744
332
2366
1.57
10.12
1.9
1.8
379.56
13046189.25
pmol/l
1.26
285
1901
273
1882
1.59
9.52
3.4
3.0
1.57
1.05
e6/l
0.81
160
1141
253
3523
0.64
8.87
3.3
3.9
6.60
9.56
mg/mmol
1.19
168
2267
118
670
1.85
8.36
1.6
1.5
—
—
—
0
0
521
4209
1.43
8.12
5.1
4.1
40.32
56.17
ng/l
0.95
439
3306
340
2533
1.49
8.12
3.6
4.2
84.73
84.14
%
0.18
334
2474
636
5345
1.42
7.86
13.5
18.9
1.24
1.37
inr
4.09
182
1507
791
8752
0.69
7.26
6.0
6.6
39.79
41.00
mmol/mol
3.60
716
7951
555
4616
1.39
6.95
2.6
2.7
—
—
—
0
0
576
4824
1.39
6.89
4.7
6.3
1.20
1.21
mmol/l
1.43
527
4379
178
2554
0.64
6.81
1.3
1.7
1.23
1.34
mmol/l
1.55
144
2087
279
2065
1.46
6.71
5.2
4.4
1.02
1.02
kg/l
0.43
45
312
261
1911
1.47
6.63
1.9
1.9
—
—
—
0
0
246
1787
1.48
6.49
3.7
3.2
1.98
1.66
e6/l
0.29
132
1052
122
759
1.68
6.31
5.6
6.6
25.92
24.38
mmol/l
5.97
117
720
236
1721
1.47
6.07
2.3
2.0
29.47
30.14
s
1.12
231
1659
194
1374
1.50
5.76
4.1
7.2
1.74
1.13
mmol/l
1.73
166
1068
189
1337
1.49
5.64
1.8
1.8
—
—
—
0
0
835
9039
0.72
5.41
4.4
5.2
6.00
6.12
mmol/l
2.15
734
8043
191
1368
1.47
5.35
4.1
7.3
5.27
5.08
kpa
2.26
183
1303
191
1369
1.47
5.33
4.1
7.2
12.35
11.78
kpa
0.72
182
1307
185
1340
1.45
4.88
1.8
1.9
—
—
—
0
0
50
258
1.98
4.80
4.8
3.6
7.32
7.71
mmol/l
0.53
50
253
52
275
1.93
4.66
4.7
3.5
1.50
1.60
mmol/l
0.47
52
270
171
1242
1.44
4.44
4.4
7.5
95.59
95.33
%
0.19
165
1195
449
3797
1.30
4.36
2.2
2.2
72.31
78.60
nmol/l
5.41
385
3289
164
1191
1.44
4.26
5.3
3.6
—
—
—
0
0
533
4620
1.29
4.25
3.9
5.0
34.95
34.63
g/l
0.70
493
4281
157
1133
1.45
4.21
4.6
8.0
123.19
120.66
g/l
0.86
152
1100
494
4258
1.28
4.06
2.6
2.3
—
—
—
0
0
442
3757
1.29
4.06
2.7
2.8
131.56
164.02
ug/l
2.42
392
3381
63
373
1.73
3.97
3.2
3.8
3.88
3.98
mmol/l
1.11
63
368
336
2767
1.30
3.90
2.4
2.2
3.37
3.11
mg/l
0.87
285
2337
218
2761
0.74
3.86
1.7
2.9
3099.72
7525.92
umol/l
1.29
166
2342
110
753
1.51
3.85
1.9
1.7
—
—
—
0
0
82
1222
0.65
3.61
3.2
4.1
3.15
23.71
ug/l
2.30
64
1029
49
822
0.58
3.54
1.3
1.7
1.42
1.63
%
2.75
43
671
89
601
1.52
3.35
3.7
3.4
25.60
25.15
mmol/l
0.78
82
581
18
71
2.56
3.30
2.8
2.4
—
—
—
0
0
15
56
2.70
3.06
1.2
2.0
—
—
—
0
0
93
1304
0.69
3.02
1.1
1.2
9.99
15.05
u/ml
0.35
35
432
7
210
0.33
2.94
1.7
5.3
—
936.18
iu/ml
—
0
34
144
1098
1.36
2.83
3.2
3.8
2.38
2.07
mmol/l
0.62
127
895
104
752
1.42
2.80
4.1
9.0
0.75
0.68
%
1.12
104
746
100
1365
0.71
2.80
1.2
1.3
29.51
38.11
iu/ml
0.44
17
418
59
887
0.65
2.74
1.2
1.3
—
—
—
0
0
20
405
0.48
2.73
1.7
1.8
—
—
—
0
0
15
60
2.52
2.71
1.7
1.4
—
—
—
0
0
87
619
1.44
2.58
3.0
2.9
0.37
0.38
e6/l
0.03
82
609
20
94
2.15
2.55
2.9
2.0
2.70
2.21
u/field
—
10
33
292
2475
1.24
2.55
2.2
2.5
—
—
—
0
0
24
439
0.54
2.42
2.6
2.7
—
—
—
0
0
6
12
5.02
2.40
2.7
2.7
0.83
0.50
u/field
—
6
12
10
251
0.39
2.40
1.6
1.3
—
—
—
0
0
250
2098
1.24
2.38
3.8
4.1
53.87
339.33
ng/l
7.68
207
1810
100
1321
0.73
2.30
4.2
4.9
35.53
32.65
%
1.87
74
865
5
157
0.32
2.27
1.0
1.2
—
—
—
0
0
101
757
1.37
2.25
4.2
8.8
1.34
1.34
%
0.00
101
751
12
48
2.52
2.19
1.4
1.4
—
—
—
0
0
949
9093
1.25
2.16
20.8
17.5
27.64
27.54
mg/l
0.03
844
7440
360
3168
1.20
2.12
2.3
2.6
51.74
85.69
u/l
0.73
331
2911
114
884
1.32
2.05
3.1
4.0
1.22
1.22
mmol/l
0.01
94
765
11
243
0.45
1.97
3.2
1.9
8.91
12.67
mg/l
1.22
11
221
931
9649
0.82
1.92
8.6
11.6
14.83
25.46
u/l
116.26
836
9230
7
173
0.40
1.91
1.1
1.1
—
—
—
0
0
14
279
0.50
1.90
1.4
1.4
—
—
—
0
0
7
22
3.19
1.88
1.0
1.1
—
—
—
0
0
7
23
3.06
1.80
1.0
1.1
—
—
—
0
0
828
8657
0.85
1.78
18.6
16.6
82.94
73.33
ml/min/173m2
40.81
718
7204
52
731
0.70
1.78
1.2
1.4
—
—
—
0
0
711
6685
1.17
1.77
3.6
3.7
15.10
15.09
pmol/l
0.04
637
5912
9
195
0.46
1.73
1.3
1.3
—
—
—
0
0
71
531
1.36
1.66
1.8
1.9
1.54
1.93
ug/l
0.18
56
468
108
1343
0.78
1.64
1.7
4.1
231.89
249.12
u/l
0.85
97
1267
21
350
0.59
1.60
1.6
1.5
—
155.38
—
0
13
7
157
0.44
1.55
1.3
2.6
—
509.00
—
0
13
12
58
2.08
1.49
3.2
1.6
77.25
90.74
umol/l
1.01
12
58
15
264
0.56
1.42
1.1
1.7
—
—
—
0
0
18
103
1.76
1.41
1.2
1.2
—
—
—
0
0
6
136
0.44
1.40
2.7
3.4
—
—
—
0
0
18
299
0.60
1.39
1.9
3.2
0.71
0.84
nmol/l
0.39
11
236
0
38
0.00
1.34
0.0
1.3
—
26.19
—
0
27
9
42
2.15
1.34
1.8
2.8
—
—
—
0
0
9
42
2.15
1.34
1.8
2.8
—
—
—
0
0
34
236
1.45
1.26
3.2
4.0
21.06
29.28
mg/l
0.98
21
149
27
398
0.67
1.25
1.1
1.1
44.10
120.42
iu/ml
—
6
139
61
781
0.77
1.21
1.7
2.2
12.83
12.45
nmol/l
0.14
52
680
31
441
0.69
1.20
2.6
3.5
21.81
9262.85
u/ml
0.84
26
372
10
50
2.01
1.16
1.1
1.2
—
—
—
0
0
19
296
0.64
1.16
1.9
2.4
149.00
110.52
ug/min
0.21
11
177
227
2019
1.15
1.15
1.7
1.7
1.52
1.47
mg/l
0.07
178
1591
378
3483
1.13
1.12
2.4
3.5
2.33
2.34
mmol/l
1.22
325
3013
197
1741
1.16
1.09
1.9
3.2
0.83
0.82
mmol/l
1.05
184
1634
726
6953
1.12
1.08
3.3
4.2
11.82
14.43
mm/h
5.06
666
6331
470
4395
1.12
1.08
4.7
5.9
61.81
58.43
%
8.59
438
4116
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
439
0.72
1.04
2.2
2.6
0.43
0.36
u/ml
0.68
21
253
22
322
0.68
1.02
1.9
1.7
—
—
—
0
0
14
226
0.61
1.01
1.5
1.4
—
—
—
0
0
252
2777
0.88
1.01
3.0
3.3
0.71
0.79
ug/l
0.61
181
1981
477
4479
1.11
1.00
4.9
6.1
23.71
25.99
%
5.12
443
4191
233
2099
1.14
0.99
2.5
3.2
2.44
2.46
mmol/l
2.37
198
1843
7
131
0.53
0.99
1.9
1.5
—
—
—
0
0
9
159
0.56
0.98
1.1
1.2
—
41.31
—
0
14
5
23
2.18
0.98
1.0
1.0
79.60
99.44
%
—
5
16
160
1405
1.16
0.98
1.6
2.5
1.50
1.80
%
4.06
139
1247
17
259
0.65
0.97
1.8
1.3
—
—
—
0
0
15
235
0.63
0.97
1.8
1.3
—
—
—
0
0
10
54
1.86
0.96
2.0
1.5
1.30
3.79
u/field
—
10
39
97
819
1.20
0.94
1.7
1.7
—
—
—
0
0
177
1573
1.15
0.92
2.1
2.6
2.28
2.25
g/l
0.40
160
1455
33
244
1.36
0.91
1.4
1.4
—
—
—
0
0
33
244
1.36
0.91
1.4
1.4
—
—
—
0
0
36
270
1.34
0.91
1.5
1.7
13410.97
15765.64
e6/l
0.15
29
198
560
5320
1.10
0.91
3.7
6.5
11.03
12.10
umol/l
1.47
524
5039
130
1488
0.86
0.90
3.3
5.7
1.01
1.03
mmol/l
0.67
121
1366
32
236
1.37
0.90
1.6
1.6
—
—
—
0
0
191
1710
1.14
0.90
2.2
2.6
10.62
12.37
umol/l
2.71
175
1590
17
254
0.66
0.89
2.1
3.0
1.46
1.83
mg/l
1.34
17
226
5
104
0.48
0.89
1.0
1.6
—
—
—
0
0
5
104
0.48
0.89
1.0
1.6
—
—
—
0
0
5
104
0.48
0.89
1.0
1.6
—
—
—
0
0
12
192
0.62
0.86
1.1
1.5
—
—
—
0
0
54
433
1.26
0.86
1.7
1.7
—
—
—
0
0
781
7561
1.10
0.82
5.1
8.0
79.18
80.88
u/l
0.47
720
7078
26
189
1.38
0.81
1.9
2.0
1.93
1.65
mmol/l
0.45
26
184
8
47
1.71
0.80
1.1
1.1
—
—
—
0
0
852
8290
1.11
0.79
4.6
4.6
2.02
2.04
mu/l
0.10
769
7383
0
24
0.00
0.79
0.0
1.9
—
—
—
0
0
91
1058
0.85
0.79
3.9
7.0
9.92
11.20
mmol/l
0.90
84
1002
33
428
0.76
0.78
1.2
3.9
24.85
87.39
mg/l
1.34
27
353
33
428
0.76
0.78
1.2
3.9
47.33
70.89
mg/l
0.75
28
350
58
477
1.23
0.76
1.7
1.9
—
—
—
0
0
31
235
1.33
0.76
1.6
1.2
480.81
552.81
mg/l
0.53
31
220
0
28
0.00
0.76
0.0
1.2
—
10.14
—
0
28
12
185
0.64
0.75
2.1
3.2
53.83
60.08
%
1.15
12
185
8
133
0.60
0.73
1.8
1.5
—
—
—
0
0
8
133
0.60
0.73
1.8
1.5
—
—
—
0
0
8
133
0.60
0.73
1.8
1.5
—
—
—
0
0
8
133
0.60
0.73
1.8
1.5
—
—
—
0
0
8
134
0.59
0.73
1.8
1.5
—
—
—
0
0
7
38
1.85
0.73
1.1
1.2
—
71.20
%
—
0
5
9
55
1.64
0.73
1.0
1.2
—
—
—
0
0
9
55
1.64
0.73
1.0
1.2
—
—
—
0
0
45
364
1.25
0.70
1.2
1.3
—
—
—
0
0
10
157
0.63
0.69
1.1
1.5
—
—
—
0
0
7
119
0.59
0.68
1.0
1.0
—
—
—
0
0
104
917
1.15
0.65
2.3
2.4
36.76
38.75
u/l
0.09
90
781
565
5430
1.08
0.64
6.1
9.2
4.36
4.28
e9/l
0.30
491
4732
6
103
0.58
0.62
1.2
1.1
—
—
—
0
0
31
244
1.28
0.61
2.5
2.7
16.59
15.67
%
0.64
18
126
25
323
0.77
0.61
1.0
1.0
—
—
—
0
0
12
175
0.68
0.60
2.0
2.9
3.65
4.52
e9/l
0.84
12
175
0
20
0.00
0.60
0.0
1.2
—
16.67
—
0
15
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
10
150
0.66
0.58
1.1
1.5
—
—
—
0
0
15
106
1.42
0.57
1.3
1.5
—
—
—
0
0
13
184
0.70
0.57
1.0
1.6
—
—
—
0
0
13
184
0.70
0.57
1.0
1.6
—
—
—
0
0
787
7680
1.08
0.57
23.1
20.6
14.86
15.56
%
2.99
776
7523
13
183
0.71
0.55
1.1
1.1
—
9.69
—
0
11
12
171
0.70
0.55
1.1
1.5
—
—
—
0
0
6
38
1.58
0.54
1.0
1.3
1.41
1.53
g/l
—
6
38
38
314
1.22
0.52
1.5
1.6
—
—
—
0
0
163
1502
1.10
0.51
2.2
2.7
19.93
22.34
%
1.25
136
1279
10
67
1.50
0.49
1.4
1.5
—
51.11
—
0
9
535
5532
0.94
0.49
2.7
3.3
43.81
57.16
u/l
1.28
490
5042
7
108
0.65
0.48
1.4
2.5
—
—
—
0
0
13
94
1.39
0.46
1.1
1.1
105.31
111.34
%
0.28
13
85
36
301
1.20
0.46
1.3
1.4
—
—
—
0
0
44
376
1.18
0.45
1.1
2.8
38.24
37.00
g/l
0.75
37
332
30
247
1.22
0.44
2.0
2.3
126.96
128.59
g/l
0.14
25
182
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
27.66
—
0
11
51
581
0.87
0.40
1.4
1.9
1.80
1.56
g/l
1.56
44
505
0
18
0.00
0.40
0.0
1.7
—
2.20
—
0
8
12
159
0.75
0.38
1.8
1.2
—
—
—
0
0
41
355
1.16
0.37
1.1
2.9
0.00
0.03
g/l
1.19
36
328
39
337
1.16
0.36
1.1
2.9
0.00
0.00
g/l
-0.00
34
311
981
9911
0.93
0.35
29.5
25.8
129.98
133.85
g/l
13.00
967
9712
981
9910
0.93
0.35
29.3
25.7
4.29
4.42
e12/l
12.18
954
9568
981
9909
0.93
0.34
29.3
25.8
38.19
39.60
%
6.80
893
9107
981
9909
0.93
0.34
29.2
25.7
241.74
237.52
e9/l
1.25
960
9601
10
73
1.37
0.34
1.3
1.4
—
—
—
0
0
10
73
1.37
0.34
1.3
1.4
—
—
—
0
0
28
329
0.85
0.34
2.4
3.3
26.35
24.96
mmol/l
1.20
28
323
469
4820
0.95
0.32
4.4
5.5
3.47
3.22
ug/l
0.14
414
4269
50
446
1.13
0.32
1.1
2.9
8.98
10.68
g/l
4.06
43
399
979
9694
1.07
0.31
24.1
20.9
139.99
139.63
mmol/l
4.89
963
9429
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
53
1.32
0.31
1.1
1.1
—
—
—
0
0
31
268
1.16
0.30
1.2
1.2
—
—
—
0
0
7
54
1.30
0.30
2.1
1.1
338.00
281.92
mg/l
—
7
48
31
270
1.15
0.28
1.2
1.2
—
—
—
0
0
304
2937
1.05
0.28
2.7
3.3
34.43
34.98
u/l
0.04
286
2782
9
116
0.77
0.27
1.0
1.8
—
—
—
0
0
45
404
1.12
0.27
1.1
3.0
0.15
1.50
g/l
4.52
35
352
980
9715
1.06
0.27
24.1
21.1
3.96
4.01
mmol/l
8.88
962
9440
175
1668
1.06
0.27
1.2
1.2
1.22
1.50
u/ml
0.19
45
415
24
278
0.86
0.26
1.0
1.6
—
—
—
0
0
23
197
1.17
0.26
1.1
1.3
0.70
0.88
nmol/l
0.99
17
158
10
127
0.79
0.25
1.0
1.5
—
—
—
0
0
10
127
0.79
0.25
1.0
1.5
—
—
—
0
0
58
532
1.10
0.24
2.4
4.1
25.11
24.05
mmol/l
2.34
58
518
23
265
0.87
0.24
1.0
1.6
—
—
—
0
0
13
158
0.82
0.23
1.1
1.1
—
—
—
0
0
16
190
0.84
0.23
1.0
1.1
—
—
—
0
0
78
835
0.93
0.23
2.6
4.0
82.08
98.91
ng/l
1.51
58
718
5
40
1.25
0.22
1.4
1.3
—
—
—
0
0
5
40
1.25
0.22
2.8
3.2
27.60
31.24
umol/l
—
5
29
371
3619
1.04
0.22
2.7
3.2
1099.41
1773.95
ng/l
5.39
317
3144
15
178
0.84
0.22
1.1
1.4
—
—
—
0
0
17
199
0.85
0.21
1.1
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
9
111
0.81
0.20
1.0
1.8
—
—
—
0
0
6
51
1.18
0.19
1.0
1.4
0.83
0.94
g/l
—
6
51
51
472
1.08
0.19
1.1
2.8
3.42
3.67
g/l
1.11
44
428
51
473
1.08
0.18
1.1
2.8
6.95
7.45
g/l
1.53
44
429
51
473
1.08
0.18
1.1
2.8
—
—
—
0
0
27
242
1.12
0.18
2.1
1.6
—
—
—
0
0
16
185
0.86
0.18
1.6
1.6
—
—
—
0
0
5
70
0.71
0.16
1.0
1.4
—
—
—
0
0
8
73
1.10
0.15
1.0
1.0
—
—
—
0
0
9
83
1.08
0.14
1.0
1.0
—
—
—
0
0
47
440
1.07
0.14
1.1
2.9
3.00
3.00
g/l
0.02
40
395
14
122
1.15
0.13
1.2
1.5
—
—
—
0
0
9
108
0.83
0.13
1.0
1.1
—
—
—
0
0
384
3900
0.98
0.13
4.0
4.7
20.34
21.53
%
1.00
197
2046
77
800
0.96
0.10
4.4
3.2
73.85
59.35
ml/min/173m2
2.05
34
341
11
96
1.15
0.10
1.1
1.6
—
—
—
0
0
135
1315
1.03
0.10
7.6
8.5
—
—
—
0
0
110
1069
1.03
0.09
2.6
2.6
6.55
6.64
ug/l
0.02
84
937
76
786
0.96
0.09
2.4
3.8
5.11
5.15
kpa
0.18
68
752
5
62
0.81
0.08
1.2
1.6
—
—
—
0
0
5
62
0.81
0.08
1.2
1.6
—
—
—
0
0
49
470
1.04
0.08
2.4
4.1
25.23
25.00
mmol/l
0.23
42
436
6
73
0.82
0.07
2.5
2.2
—
—
—
0
0
15
163
0.92
0.07
1.1
1.6
—
—
—
0
0
99
1013
0.98
0.06
1.2
2.9
65.70
66.23
g/l
0.32
85
923
110
1121
0.98
0.05
2.1
2.8
7.80
9.41
umol/l
0.40
98
996
14
130
1.08
0.04
3.3
2.8
—
—
—
0
0
29
279
1.04
0.04
2.1
3.1
8.26
7.75
kpa
1.40
29
273
14
149
0.94
0.03
1.1
1.3
—
—
—
0
0
103
1016
1.02
0.03
2.0
2.2
0.20
0.20
g/l
0.21
93
945
75
739
1.02
0.02
2.4
3.7
2.48
1.98
mmol/l
0.60
52
556
10
93
1.08
0.02
1.0
1.0
—
—
—
0
0
82
827
0.99
0.01
1.7
2.1
425.84
367.08
nmol/l
2.07
73
744
10
94
1.06
0.01
1.8
1.3
—
—
—
0
0
10
101
0.99
0.00
1.1
1.1
—
—
—
0
0
106
1058
1.00
0.00
2.6
3.0
236.29
226.84
ng/l
0.08
96
974
30
301
1.00
0.00
1.3
1.5
274.98
272.49
ug/g
0.02
25
184
34
341
1.00
0.00
1.1
1.3
—
—
—
0
0
13
127
1.02
0.00
1.1
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
18.75
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
24.17
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.0
—
74.80
—
0
5
6
59
1.02
-0.00
1.3
1.4
—
—
—
0
0
7
75
0.93
-0.00
1.1
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
2.50
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
6.2
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
6
62
0.97
-0.00
1.7
1.4
—
—
—
0
0
6
59
1.02
-0.00
1.3
1.4
—
—
—
0
0
6
62
0.97
-0.00
1.7
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
5
58
0.86
-0.00
1.4
1.2
9.98
9.92
mmol/l
—
5
53
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR – Use of levodopa decarbox-comt-inhibitor
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).